Elevation Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ELEV and buy or sell other stocks, ETFs, and their options commission-free!About ELEV
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion.
CEOKevin C. Tang
CEOKevin C. Tang
Employees34
Employees34
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2019
Founded2019
Employees34
Employees34
ELEV Key Statistics
Market cap21.62M
Market cap21.62M
Price-Earnings ratio-0.45
Price-Earnings ratio-0.45
Dividend yield—
Dividend yield—
Average volume575.88K
Average volume575.88K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.26
52 Week high$2.26
52 Week low$0.221
52 Week low$0.221
Stock Snapshot
With a market cap of 21.62M, Elevation Oncology(ELEV) trades at $0.37. The stock has a price-to-earnings ratio of -0.45.
On 2025-12-04, Elevation Oncology(ELEV) stock opened at —, reached a high of —, and a low of —.
The Elevation Oncology(ELEV)'s current trading volume is 0, compared to an average daily volume of 575.88K.
During the past year, Elevation Oncology(ELEV) stock moved between $0.22 at its lowest and $2.26 at its peak.
During the past year, Elevation Oncology(ELEV) stock moved between $0.22 at its lowest and $2.26 at its peak.
People also own
Based on the portfolios of people who own ELEV. This list is generated using Robinhood data, and it’s not a recommendation.